Nurix Therapeutics, Inc. - Common Stock (NRIX)

Historical Holders from Q3 2020 to Q3 2025

Symbol
NRIX on Nasdaq
CUSIP
67080M103
Type / Class
Equity / Common Stock
Shares outstanding
76.6M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
88.3M
Holdings value
$1.01B
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
162
Number of buys
91
Number of sells
-72
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nurix Therapeutics, Inc. - Common Stock (NRIX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 13.4% -7.33% $122M -$714K 10.2M -0.58% FMR LLC Mar 31, 2025
BlackRock, Inc. 8.2% $74.7M 6.28M BlackRock, Inc. Mar 31, 2025
Deep Track Capital, LP 7.21% +35.4% $65.3M $16.3M 5.5M +33.3% Deep Track Capital, LP Mar 31, 2025
COMMODORE CAPITAL LP 5.1% $45.7M 3.85M COMMODORE CAPITAL LP Feb 7, 2025
WELLINGTON MANAGEMENT GROUP LLP 4.2% $37.9M 3.19M Wellington Management Group LLP Mar 31, 2025

Institutional Holders of Nurix Therapeutics, Inc. - Common Stock (NRIX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 711 $6.57K -$1.16K $9.24 1
2025 Q2 88.3M $1.01B +$40.9M $11.39 162
2025 Q1 84.6M $1.01B +$28.7M $11.88 168
2024 Q4 81.1M $1.53B +$232M $18.84 173
2024 Q3 67.6M $1.52B +$52.6M $22.47 169
2024 Q2 65M $1.36B +$344M $20.87 172
2024 Q1 48.9M $718M +$58.2M $14.70 136
2023 Q4 139K $1.43M +$215K $10.32 3
2023 Q3 44.8M $352M +$8.51M $7.86 127
2023 Q2 43.6M $435M +$11.8M $9.99 122
2023 Q1 42.3M $375M -$3.62M $8.88 118
2022 Q4 42.7M $469M +$2.14M $10.98 118
2022 Q3 42.6M $555M -$36.7M $13.03 111
2022 Q2 43.5M $551M +$51.9M $12.67 96
2022 Q1 40.1M $561M -$19.1M $14.01 108
2021 Q4 40.4M $1.17B +$25.7M $28.95 117
2021 Q3 38.9M $1.17B -$6.52M $29.96 109
2021 Q2 39.1M $1.04B -$75.6M $26.53 101
2021 Q1 41.3M $1.29B +$255M $31.09 98
2020 Q4 33.1M $1.09B +$26.9M $32.88 67
2020 Q3 31.9M $1.11B +$1.11B $34.91 64